Credits
Host: Sara Dong
Guest: Gabriella Lamb
Writing/Producing/Editing/Cover Art/Infographics: Sara Dong
Our Guest
Gabriella Lamb, MD, MPH
Dr. Lamb completed undergrad at Boston University, and then moved to Texas – where she attended medical school at Baylor College of Medicine, pediatric residency at University of Texas Southwestern in Dallas, and then pediatric ID fellowship at Texas Children’s Hospital. While in fellowship, she obtained her MPH at the University of Texas Houston. Dr. Lamb then relocated to Boston to work at Boston Children’s Hospital in August 2019. At Boston Children’s, she is a clinician educator and the director of quality improvement for the division of infectious diseases.
Culture
Gabby told us about how she loved attending the ballet pre-pandemic, and she takes time to find ways to watch performances online instead!
Consult Notes
Consult Q
5 yo boy with fever and belly pain. Please help with antibiotics and work-up
One-liner
5 year old previously healthy boy found to have MSSA liver abscess and new diagnosis of chronic granulomatous disease
Key Points
Jump to:
Let’s talk about microbiology of hepatic abscesses first! What pathogens do you need to consider?
- Pyogenic liver abscesses in children are often polymicrobial. Infections can be caused by aerobic, facultative, or anaerobic bacteria:
- Enteric gram negative organisms (E.coli, Klebsiella, Enterobacter, Salmonella) or Pseudomonas
- S.aureus, Strep spp., E.faecalis
- Amebic abscesses (E.histolytica) can occur and may be difficult to distinguish from a pyogenic infection. Organisms reach the liver through the portal venous system and usually cause a single, large abscess. This possibility should be considered particularly in those who have lived in or traveled to endemic area (e.g., Africa, India, Mexico, and other parts of Central and South America)
- Other parasitic infections (including ascariasis) have been associated with hepatic abscess
- Granulomas induced by these infections are recognized as likely predisposing factors for pyogenic liver abscesses in children in endemic areas
- Pereira FE, Musso C, Castelo JS. Pathology of pyogenic liver abscess in children. Pediatr Dev Pathol. 1999;2(6):537-543. doi:10.1007/s100249900159
- Moreira-Silva SF, Pereira FE. Intestinal nematodes, Toxocara infection, and pyogenic liver abscess in children: a possible association. J Trop Pediatr. 2000;46(3):167-172. doi:10.1093/tropej/46.3.167
- Liver abscesses can be due to:
- Direct extension from local infection (such as cholecystitis or cholangitis)
- Hematogenous spread through hepatic artery or through portal vein from sources within abdominal cavity (e.g. appendicitis). Historically, appendicitis was a common cause of pyogenic liver abscesses, but this cause has decreased significantly with antibiotics and early surgical intervention
- Traumatic injury, particularly in patients managed operatively and in those with concurrent injury to a hollow viscus
- Other pathogens that might cause liver lesions, but likely appear differently on imaging compared to pyogenic liver abscess:
- Cat scratch disease (Bartonella) is associated with multiple microabscesses of the liver and spleen. This can be seen in otherwise healthy children or in immunocompromised children
- M.tuberculosis: uncommon, often as multiple small abscesses as in miliary TB
- Burkholderia pseudomallei (melioidosis)
- Echinococcus spp: hepatic hydatid cysts
- Candida spp can cause hepatosplenic candidiasis, often with microabscesses
- Endemic fungal infections
How will a child with a liver abscess present? Look for:
- Fever
- Abdominal pain (diffuse or localized to RUQ); Tender hepatomegaly
- Might have referred pain to shoulder or a cough
- Nausea
- Vomiting
- Anorexia
- Jaundice is less common but can occur when abscess compresses biliary tract or parasitic infections (e.g., ascariasis) obstruct a bile duct lumen
- Elevated WBC count or LFTs
- Elevated inflammatory markers
Important additional history questions:
- Travel history (if traveled to or lived in any endemic areas of parasitic infection)
- Recent trauma, infection, or surgery
- Kitten/cat or other animal exposure
How to manage hepatic abscess?
Antibiotic therapy alone has been successful. Start with broad-spectrum antibiotics with activity against the most common organisms associated with the type of abscess identified.
- May need to consider antifungal therapy in immunocompromised patients
- Multiple microabscesses are also treated successfully with antibiotics alone, especially in cases of cat scratch disease
Decisions regarding drainage are based on clinical presentation, condition of patient, need for micro confirmation. Optimal treatment strategies for liver abscess in children are not totally clear given rarity of presentation and are mostly inferred from adult cases. Here is a summary of what is noted in Long’s Principles and Practice of Pediatric ID text:
- Abscesses smaller than 4cm in diameter can be successfully treated by aspiration, with antibiotic therapy continued until patient’s clinical status improves and CT shows resolution of abscess
- If abscess >4 cm or recurrence after aspiration, continuous drainage using CT or US-guided percutaneous catheter is indicated in addition to antibiotic therapy
- Surgical drainage recommended with liver abscess that does not resolve with percutaneous drainage, those with rupture into peritoneal cavity, in patients with CHD who have persistent or recurrent liver abscesses
Here are a few papers related to liver abscess. Also check out recommended chapters at the end of the Consult Notes for textbook options.
- A review of liver abscess in children. Mishra K, Basu S, Roychoudhury S, Kumar P. Liver abscess in children: an overview. World J Pediatr. 2010;6(3):210-216. doi:10.1007/s12519-010-0220-1
- A recent population-based analysis of pediatric pyogenic liver abscess. Thavamani A, Umapathi KK, Khatana J, Roy A, Augustin T, Radhakrishnan K. Incidence Trends, Comorbidities, and Outcomes of Pyogenic Liver Abscess Among Children: A Nationwide Population-based Analysis. J Pediatr Gastroenterol Nutr. 2020;71(1):106-111. doi:10.1097/MPG.0000000000002700
- A look at etiology and mortality of pyogenic liver abscesses in adults. Rahimian J, Wilson T, Oram V, Holzman RS. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis. 2004;39(11):1654-1659. doi:10.1086/425616
- Bamberger DM. Outcome of medical treatment of bacterial abscesses without therapeutic drainage: review of cases reported in the literature. Clin Infect Dis. 1996;23(3):592-603. doi:10.1093/clind/23.1.592
- A description of the imaging features of different liver infections and how to avoid pitfalls in image interpretation. Bächler P, Baladron MJ, Menias C, et al. Multimodality Imaging of Liver Infections: Differential Diagnosis and Potential Pitfalls. Radiographics. 2016;36(4):1001-1023. doi:10.1148/rg.2016150196
Now let’s change gears to talk more about chronic granulomatous disease (CGD). Some of the basics:
- CGD affects ~1 per 200-250,000 live births in the US. Primarily males since >50-70% of mutations are X-linked
- CGD may present at any time from infancy to late adulthood, but most are diagnosed as toddlers or children before the age of 5
- Adult or late childhood presentations might be more related to milder cases of autosomal recessive CGD
- Although CGD was initially considered fatal, the prognosis has improved due to prophylactic antimicrobials and other treatments. Many people affected by CGD live into adulthood with an estimated survival of 90% now.
- Pathogenesis:
- Impaired function of phagocyte respiratory burst resulting from inherited mutations in 1 of the 5 phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase genes. Also called the phagocyte oxidase or phox complex)
- This defect results in the inability of phagocytes (neutrophils, macrophages, monocytes) to generate superoxide to destroy certain microbes
- Mutations in all 5 structural genes of NADPH oxidase have been found to cause CGD
- Components can be membrane bound (gp91-phox, gp22-phox) and cytosolic (p47-phox, p67-phox, p40-phox).
- Mutations in gp91-phox account for ~65% of cases; p47-phox ~25%; remainder divided between p67-phox and p22-phox
- Some reading on CGD:
- A review of CGD. If you could only read one paper about CGD, this would be an excellent one to use! Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27(1):89-viii. doi:10.1016/j.hoc.2012.11.002
- A review of epidemiology, pathophysiology, and genetics of CGD: Rider NL, Jameson MB, Creech CB. Chronic Granulomatous Disease: Epidemiology, Pathophysiology, and Genetic Basis of Disease. J Pediatric Infect Dis Soc. 2018;7(suppl_1):S2-S5. doi:10.1093/jpids/piy008
- Here is a single-center US experience with CGD from Lurie Children’s: Bortoletto P, Lyman K, Camacho A, Fricchione M, Khanolkar A, Katz BZ. Chronic Granulomatous Disease: A Large, Single-center US Experience. Pediatr Infect Dis J. 2015;34(10):1110-1114. doi:10.1097/INF.0000000000000840
How do you diagnose CGD?
- You can diagnose by examining neutrophil function testing
- Dihydrorhodamine (DHR) 123 flow cytometry assay
- Has ability to distinguish between X-linked and autosomal forms
- Has ability to detect gp91 phox carriers
- MPO deficiency and SAPHO syndrome can give false abnormal DHR
- Nitroblue tetrazolium reduction (NBT) test
- Dihydrorhodamine (DHR) 123 flow cytometry assay
- After initial labs, genetic testing will follow. Sequencing a patient’s phagocyte oxidase (phox) genes to determine exact molecular defect is recommended.
- Read more about diagnosis here: Yu JE, Azar AE, Chong HJ, Jongco AM 3rd, Prince BT. Considerations in the Diagnosis of Chronic Granulomatous Disease. J Pediatric Infect Dis Soc. 2018;7(suppl_1):S6-S11. doi:10.1093/jpids/piy007
What are the major clinical manifestations of CGD?
- Patients will have recurrent or severe infections by bacteria or fungi
- Bacterial infections are often symptomatic with fever or elevated inflammatory markers (but only mild leukocytosis).
- Fungal infections may only have a few symptoms and only noted while screening for infection or at an advanced stages
- Most common sites of serious infection in CGD (more frequent to less frequent):
- Pneumonia
- Abscesses (skin, tissue, or visceral)
- Suppurative adenitis
- Osteomyelitis
- Bacteremia/fungemia
- Superficial skin infections (cellulitis/impetigo)
- Children may also demonstrate growth failure / failure to thrive
Patients with CGD may have chronic respiratory disease (bronchiectasis, obliterative bronchiolitis, chronic fibrosis), and we also discussed the clinical entity of “mulch pneumonitis” on the show. What is mulch pneumonitis?
- A severe acute respiratory failure after high level exposure to aerosolized fungi. This acute fulminant invasive fungal pneumonia in absence of iatrogenic or exogenous immunosuppression is a medical emergency highly associated with CGD
- The patient inhales large burden of fungal spores and hyphae → develop syndrome of acute dyspnea, hypoxia, fever, and evidence of pulmonary infiltrates → symptoms can progress to fulminant respiratory failure and death within 1 to 10 days after inhalation
- Possible exposures: cleaning gutters with dead leaves, heavy mulching, wood chipping, lawn mowing — really anything with significant amounts of exposure to mulch, trees, hay, moss, dirt, or other organic matter
- Patients have been most successfully managed if treated with both glucocorticoids and antifungals.
- The correct diagnosis is important for therapy at time of presentation but also for genetic counseling and subsequent prophylaxis afterwards.
We also discussed on the show that CGD patients are prone to granulomas of any hollow viscus, but how this can be especially problematic in the GI tract.
- Gastric outlet obstruction might be initial presentation of CGD
- Patients can develop CGD granulomatous colitis that mimics Crohns disease → 43% of CGD patients followed at NIH with X-linked CGD had symptomatic biopsy-proven inflammatory bowel disease
- Median age of GI symptom presentation was 5 years
- Treatment of CGD-associated IBD is difficult and prone to relapse:
- Steroids are effective but have significant adverse effects
- TNFa agents, like Infliximab, are highly effective for CGD-IBD but carry a high risk of death and worse outcomes (compared to typical patients with Crohn’s disease and use of TNFa agent)
- Use of TNFa agent requires aggressive antimicrobial prophylaxis and surveillance for more severe infection with typical CGD pathogens
- Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114(2):462-468. doi:10.1542/peds.114.2.462
- Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51(12):1429-1434. doi:10.1086/657308
- Henrickson SE, Jongco AM, Thomsen KF, Garabedian EK, Thomsen IP. Noninfectious Manifestations and Complications of Chronic Granulomatous Disease. J Pediatric Infect Dis Soc. 2018;7(suppl_1):S18-S24. doi:10.1093/jpids/piy014
Liver abscesses are estimated to occur in about ⅓ of patients with CGD. We discussed how liver abscesses may have distinct characteristics in the setting of CGD.
- Pyogenic liver abscesses in CGD are phenotypically distinct: Abscesses are often septate masses surrounded by a thick pseudocapsule containing dense inspissated fluid and amorphous cell debris
- Can be homogeneously enhancing while small and then develop multiple locules separated by thick enhancing septations as they enlarged → often intense halo of enhancement around abscess, likely representing granulation tissue.
- Lublin M, Bartlett DL, Danforth DN, et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg. 2002;235(3):383-391. doi:10.1097/00000658-200203000-00010
- Garcia-Eulate R, Hussain N, Heller T, et al. CT and MRI of hepatic abscess in patients with chronic granulomatous disease. AJR Am J Roentgenol. 2006;187(2):482-490. doi:10.2214/AJR.05.1386
Do liver abscesses in the setting of CGD require different management?
- Classically, these abscesses are thought to almost always require surgery due to dense, caseous nature with difficult to drain fluid. While surgical resection for liver abscess refractory to medical treatment is effective with low mortality, surgical morbidity may affect 56% of cases. This has led some to favor debridement and percutaneous drainage when possible
- An emerging approach is treatment of CGD-associated liver abscesses with high dose steroids added to the targeted IV antibiotics. This is an attempt to modify the underlying inflammatory response.
- Straughan DM, McLoughlin KC, Mullinax JE, et al. The Changing Paradigm of Management of Liver Abscesses in Chronic Granulomatous Disease. Clin Infect Dis. 2018;66(9):1427-1434. doi:10.1093/cid/cix1012
- This paper compares the biochemical and clinical outcomes of CGD patients with liver abscesses treated with open surgery (OS), percutaneous drainage (IR), or steroid management (CM)
- Of the 268 CGD patients managed at NIH from 1980-2014, 88 patients had liver involvement (26 with records to examine the questions)
- Found improved LFTs, fewer subsequent hepatic interventions, and prolonged intervention free interval in steroid management cases compared to procedural intervention
- This paper suggested that invasive therapy may not be optimal for all CGD liver abscesses, and steroids may reduce systemic inflammation, immune infiltration, and capillary leak (improving liver function).
- This paper compares the biochemical and clinical outcomes of CGD patients with liver abscesses treated with open surgery (OS), percutaneous drainage (IR), or steroid management (CM)
What are the important organisms of concern in patients with CGD?
Classically we learn that “catalase-positive microorganisms” cause the most issues, but this can encompass most bacterial and all fungal pathogens. Plus, catalase is not necessary or sufficient alone for pathogenicity in CGD.
Here is a list of the must-know organisms in the setting of CGD (North America):
- Staph aureus
- Serratia marcescens
- Burkholderia cepacia
- Nocardia
- Aspergillus spp
Outside of North America, Salmonella and BCG are frequent infections and should suggest the diagnosis. Consider mycobacterial infection in endemic settings!
Others that should ring alarm bells: Chromobacterium violaceum, Francisella philomiragia, Burkholderia gladioli, Granulibacter bethesdensis, Paecilomyces spp, Exophiala dermatidis
A few notes/pearls about this list:
- S.aureus: Common sites of infections while on prophylaxis include liver, lymph nodes, or skin infection
- S.marcescens: Commonly causes bone and soft tissue infections in infants
- B.cepacia: Common sites of infection are pneumonia or bacteremia
- Patients with CGD are prone to recurrent pulmonary infections with different strains of Burkholderia, unlike patients with CF who tend to have chronic infection with same strain: Greenberg DE, Goldberg JB, Stock F, Murray PR, Holland SM, Lipuma JJ. Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center. Clin Infect Dis. 2009;48(11):1577-1579. doi:10.1086/598937
- Nocardia spp often cause pneumonia, brain, or liver infections
- Aspergillus spp often affect lung, spine, or cause miliary disease in CGD
- Specific exposures that might be problematic: gardening, yard work, lawn mowing, leaf raking, mulching
- A.nidulans infects patients with CGD almost exclusively: Henriet SS, Verweij PE, Warris A. Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction. J Infect Dis. 2012;206(7):1128-1137. doi:10.1093/infdis/jis473
- Although filamentous molds are almost pathognomonic for CGD, endemic dimorphic mold infections (histo, blasto, coccidio) and cryptococcosis do not seem to occur more frequently in CGD.
- Here is a summary of 268 patients with confirmed CGD followed by the NIH from 1969-2012. The mean follow-up per patient was 10 years. Marciano BE, Spalding C, Fitzgerald A, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60(8):1176-1183. doi:10.1093/cid/ciu1154
- Bennett N, Maglione PJ, Wright BL, Zerbe C. Infectious Complications in Patients With Chronic Granulomatous Disease. J Pediatric Infect Dis Soc. 2018;7(suppl_1):S12-S17. doi:10.1093/jpids/piy013
What should be used for prophylaxis in CGD?
Although there is limiting data examining the approach, lifelong antimicrobial prophylaxis for CGD patients is considered standard of care. Typically patients will receive trimethoprim-sulfamethoxazole (TMP-SMX) and itraconazole
- TMP-SMX has been routine since the 1980s.
- Retrospective series showed TMP-SMX altered the frequency of infections from ~ 1 per year to 1 every 4 years (Staph infections in particular): Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162(3):723-726. doi:10.1093/infdis/162.3.723
- In this summary, most patients were treated with long term antibiotics and antifungal prophylaxis. Most used TMP-SMX 6 mg/kg/d TMP divided twice daily Marciano BE, Spalding C, Fitzgerald A, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60(8):1176-1183. doi:10.1093/cid/ciu1154
- Typical dosing for prevention of infection in CGD is 5 mg/kg per day (based on TMP component), up to 1 DS tablet daily
- In addition to its antimicrobial spectrum, TMP-SMX concentrates in polymorphonuclear cells and does not eradicate anaerobic gut microbes
- Itraconazole has been used based on observational series and a single randomized trial. Rates of fungal infections are generally low.
- Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348(24):2416-2422. doi:10.1056/NEJMoa021931
- In this summary, continuous antifungal use was noted in 70%, mostly Itraconazole 100 or 200mg daily according to weight. Marciano BE, Spalding C, Fitzgerald A, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60(8):1176-1183. doi:10.1093/cid/ciu1154
- With the emergence of resistant organisms, voriconazole and posaconazole use has increased — but majority of centers likely still are using itraconazole prophylaxis
- Slack MA, Thomsen IP. Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease. J Pediatric Infect Dis Soc. 2018;7(suppl_1):S25-S30. doi:10.1093/jpids/piy016
What other treatment is available for CGD?
- IFNg reduced the number and severity of infections in CGD by 70%, regardless of inheritance pattern, sex, or use of prophylaxis in this large multinational multicenter RCT: A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med. 1991;324(8):509-516. doi:10.1056/NEJM199102213240801
- You can read more about gene therapy here: Grez M, Reichenbach J, Schwäble J, Seger R, Dinauer MC, Thrasher AJ. Gene therapy of chronic granulomatous disease: the engraftment dilemma. Mol Ther. 2011;19(1):28-35. doi:10.1038/mt.2010.232
- Hematopoietic stem cell transplantation can lead to stable remission of CGD, and regimens have ranged from full myeloablation to non-myeloablative conditioning.
- Cole T, Pearce MS, Cant AJ, Cale CM, Goldblatt D, Gennery AR. Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Imm
- Kang EM, Marciano BE, DeRavin S, Zarember KA, Holland SM, Malech HL. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2011;127(6):1319-1328. doi:10.1016/j.jaci.2011.03.028
Other miscellaneous mentions and notes:
- Like textbooks?
- Mandell, Principles and Practice of ID, 8th Ed., 9th Ed.:
- Chapter 77: Infections of the liver and biliary system (liver abscess, cholangitis, cholecystitis)
- Chapter 12: Evaluation of the patient with suspected immunodeficiency
- Long, Principles and Practice of Pediatric ID, 5th Ed.:
- Chapter 67: Intra-abdominal, visceral, and retroperitoneal abscesses
- Chapter 104: Infectious complications of dysfunction or deficiency of polymorphonuclear and mononuclear phagocytes
- Comprehensive Review of Infectious Diseases
- Mandell, Principles and Practice of ID, 8th Ed., 9th Ed.:
- You can find several of the articles on CGD above in JPIDS’s supplement: “Chronic Granulomatous Disease: A Saga of Discovery and Understanding”
Episode Art & Infographics
Goal
Listeners will be able to discuss pyogenic liver abscess in the setting of chronic granulomatous disease.
Learning Objectives
After listening to this episode, listeners will be able to:
- List the common etiologies of pyogenic liver abscess
- Compare typical pyogenic liver abscess to liver abscess in setting of chronic granulomatous disease
- Describe pathophysiology of chronic granulomatous disease
- List the top 5 pathogens to consider with CGD-associated infections
Disclosures
Our guest (Gabriella Lamb) as well as the Febrile podcast and hosts report no relevant financial disclosures.
Citation
Lamb, G.., Dong, S. “#4: a Case of Gut Discomfort”. Febrile: A Cultured Podcast. https://player.captivate.fm/episode/86521705-0300-43f5-8010-3a4cf00797d3